Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
This entry reports the completion of an observational longitudinal study in children with idiopathic growth hormone deficiency, sponsored by…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
A non-interventional, observational study of patients using Norditropin for growth hormone deficiency and Turner syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm [Phase 3]
Phase 3 clinical trial evaluating Genotonorm for growth rate in children with growth retardation due to glucocorticosteroid therapy; study c…
-
FDA approval · 2015-06-12FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals, likely to update labeling or expand indicati…
-
FDA approval · 2015-05-26FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, adding/confirming a formulation strength unde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device
Clinical trial evaluating adherence to and patient acceptability of Zomacton administered with the Zomajet Vision X device was terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Safety and Efficacy of Long-term Somatropin Treatment in Adults
A completed clinical trial evaluated the long-term safety and efficacy of somatropin treatment in adults with growth hormone deficiency, pro…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®
An observational study validating a scoring system to quantify the therapeutic response to Norditropin in adults with growth hormone deficie…
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Growth Hormone (GH) Deficiency & Insulin Like Growth Factor 1 (IGF-I)/ Insulin Like Growth Factor Binding Protein 3 (IGFBP-3) Ratio
A completed study from the University of Jordan evaluating the diagnostic utility of the IGF-I/IGFBP-3 ratio for growth hormone deficiency.
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury. [Phase 4]
Pfizer-sponsored Phase 4 trial evaluating growth hormone replacement for adults with growth hormone deficiency after traumatic brain injury …
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT) [Phase 3]
Phase 3 trial update on the metabolic effects of growth hormone and IGF-I in growth hormone deficiency with diabetes and impaired glucose to…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia [Phase 4]
Phase 4 clinical trial evaluating endocrine dysfunction and growth hormone deficiency in children with optic nerve hypoplasia (Septo-optic d…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Safety and Efficacy of Long-term Somatropin Treatment in Children
Clinical trial update reporting long-term safety and efficacy of somatropin treatment in pediatric patients with growth-related conditions.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
Clinical trial update on the effects of growth hormone on cardiac function, as measured by echocardiography, in growth hormone-deficient pat…
-
FDA approval · 2015-01-23FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, resulting in an approved supplemental indication/lab…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency
This clinical trial update reports the observational study evaluating safety and efficacy of Norditropin (somatropin) in adults with growth …
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children [Phase 4]
This document reports a Phase IV clinical trial evaluating pegylated somatropin for growth hormone deficiency in children. The current statu…
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Constructing an Insulin-Like Growth Factor-based Prediction Model
The trial update describes efforts to construct an insulin-like growth factor–based predictive model for growth disorders (Growth Hormone De…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency [Phase 3]
A Phase 3 trial comparing the Growth Hormone Releasing Hormone plus Arginine test for diagnosing adult growth hormone deficiency has complet…
-
FDA approval · 2014-07-30FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humatrope (somatropin) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood [Phase 4]
Completed Phase 4 multicentre randomized trial assessing the effects of Saizen on cardiac function in growth hormone deficient individuals t…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Testosterone and Growth Hormone for Bone Loss in Men [Phase 2]
Phase 2 clinical trial evaluating testosterone and growth hormone (somatropin) for bone loss in men with hypopituitarism or related hormone …
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: GH and Cardiovascular Risk Factors [Phase 4]
Phase 4 clinical trial update on growth hormone and cardiovascular risk factors; the Amsterdam UMC study has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector
A completed clinical trial evaluated the convenience and adherence of the Easypod electronic self-injector for growth hormone therapy in con…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Metabolic Endocrinology and Growth Hormone in Adults
This update notes the completion of a Merck KGaA-sponsored clinical trial studying growth hormone treatment in adults with adult growth horm…